{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:44Z","timestamp":1792047824653,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/gt.2016.61","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T14:43:36Z","timestamp":1471013016000},"page":"846-856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts"],"prefix":"10.1038","volume":"23","author":[{"given":"H","family":"Khonsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Al-Mahdawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y G","family":"Chianea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Themis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Parris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Pook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Themis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,15]]},"reference":[{"key":"BFgt201661_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo M . Friedreich ataxia: the clinical picture. J Neurol 2009; 256: 3\u20138.","journal-title":"J Neurol"},{"key":"BFgt201661_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/0883073812448230","volume":"27","author":"MB Delatycki","year":"2012","unstructured":"Delatycki MB, Corben LA . Clinical features of Friedreich ataxia. J Child Neurol 2012; 27: 1133\u20131137.","journal-title":"J Child Neurol"},{"key":"BFgt201661_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/0883073812448534","volume":"27","author":"M Pandolfo","year":"2012","unstructured":"Pandolfo M . Friedreich ataxia new pathways. J Child Neurol 2012; 27: 1204\u20131211.","journal-title":"J Child Neurol"},{"key":"BFgt201661_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","volume":"303","author":"AH Koeppen","year":"2011","unstructured":"Koeppen AH . Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011; 303: 1\u201312.","journal-title":"J Neurol Sci"},{"key":"BFgt201661_CR5","first-page":"852080","volume":"2013","author":"C Sandi","year":"2013","unstructured":"Sandi C, Al-Mahdawi S, Pook MA . Epigenetics in Friedreich's ataxia: challenges and opportunities for therapy. Genet Res Int 2013; 2013: 852080.","journal-title":"Genet Res Int"},{"key":"BFgt201661_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0883073812448535","volume":"27","author":"RM Payne","year":"2012","unstructured":"Payne RM, Wagner GR . Cardiomyopathy in Friedreich ataxia: clinical findings and research. J Child Neurol 2012; 27: 1179\u20131186.","journal-title":"J Child Neurol"},{"key":"BFgt201661_CR7","doi-asserted-by":"publisher","first-page":"38486","DOI":"10.1074\/jbc.M110.145144","volume":"285","author":"O Gakh","year":"2010","unstructured":"Gakh O, Bedekovics T, Duncan SF, Smith DY, Berkholz DS, Isaya G . Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron\u2013sulfur cluster assembly. J Biol Chem 2010; 285: 38486\u201338501.","journal-title":"J Biol Chem"},{"key":"BFgt201661_CR8","doi-asserted-by":"publisher","first-page":"e16199","DOI":"10.1371\/journal.pone.0016199","volume":"6","author":"S Schmucker","year":"2011","unstructured":"Schmucker S, Martelli A, Colin F, Page A, Wattenhofer-Donze M, Reutenauer L et al. Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU\/NFS1\/ISD11 iron\u2013sulfur assembly complex. PLoS One 2011; 6: e16199.","journal-title":"PLoS One"},{"key":"BFgt201661_CR9","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","volume":"96","author":"R Lodi","year":"1999","unstructured":"Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 1999; 96: 11492\u201311495.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201661_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2013.04.005","volume":"1514","author":"TE Richardson","year":"2013","unstructured":"Richardson TE, Kelly HN, Amanda EY, Simpkins JW . Therapeutic strategies in Friedreich's ataxia. Brain Res 2013; 1514: 91\u201397.","journal-title":"Brain Res"},{"key":"BFgt201661_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD . Genomic instability\u2014an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010; 11: 220\u2013228.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFgt201661_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1074\/jbc.M511064200","volume":"281","author":"TJ Schulz","year":"2006","unstructured":"Schulz TJ, Thierbach R, Voigt A, Drewes G, Mietzner B, Steinberg P et al. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 2006; 281: 977\u2013981.","journal-title":"J Biol Chem"},{"key":"BFgt201661_CR13","doi-asserted-by":"publisher","first-page":"e1000812","DOI":"10.1371\/journal.pgen.1000812","volume":"6","author":"AC Haugen","year":"2010","unstructured":"Haugen AC, Di Prospero NA, Parker JS, Fannin RD, Chou J, Meyer JN et al. Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet 2010; 6: e1000812.","journal-title":"PLoS Genet"},{"key":"BFgt201661_CR14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/hmg\/11.11.1351","volume":"11","author":"G Karthikeyan","year":"2002","unstructured":"Karthikeyan G, Lewis LK, Resnick MA . The mitochondrial protein frataxin prevents nuclear damage. Hum Mol Genet 2002; 11: 1351\u20131362.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR15","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/jnnp.45.12.1136","volume":"45","author":"S Chamberlain","year":"1982","unstructured":"Chamberlain S, Lewis PD . Studies of cellular hypersensitivity to ionising radiation in Friedreich's ataxia. J Neurol Neurosurg Psychiatry 1982; 45: 1136\u20131138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFgt201661_CR16","doi-asserted-by":"publisher","first-page":"e0151026","DOI":"10.1371\/journal.pone.0151026","volume":"11","author":"Y Shen","year":"2016","unstructured":"Shen Y, McMackin MZ, Shan Y, Raetz A, David S, Cortopassi G . Frataxin deficiency promotes excess microglial DNA damage and inflammation that is rescued by PJ34. PloS one 2016; 11: e0151026.","journal-title":"PloS one"},{"key":"BFgt201661_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1096\/fj.05-5709com","volume":"21","author":"JV Llorens","year":"2007","unstructured":"Llorens JV, Navarro JA, Mart\u00ednez-Sebasti\u00e1n MJ, Baylies MK, Schneuwly S, Botella JA et al. Causative role of oxidative stress in a Drosophila model of Friedreich ataxia. FASEB J 2007; 21: 333\u2013344.","journal-title":"FASEB J"},{"key":"BFgt201661_CR18","doi-asserted-by":"publisher","first-page":"e21017","DOI":"10.1371\/journal.pone.0021017","volume":"6","author":"JA Navarro","year":"2011","unstructured":"Navarro JA, Llorens JV, Soriano S, Botella JA, Schneuwly S, Mart\u00ednez-Sebasti\u00e1n MJ et al. Overexpression of human and fly frataxins in Drosophila provokes deleterious effects at biochemical, physiological and developmental levels. PloS one 2011; 6: e21017.","journal-title":"PloS one"},{"key":"BFgt201661_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.febslet.2004.07.022","volume":"572","author":"CJ Miranda","year":"2004","unstructured":"Miranda CJ, Santos MM, Ohshima K, Tessaro M, Sequeiros J, Pandolfo M . Frataxin overexpressing mice. FEBS Lett 2004; 572: 281\u2013288.","journal-title":"FEBS Lett"},{"key":"BFgt201661_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","volume":"20","author":"M Perdomini","year":"2014","unstructured":"Perdomini M, Belbellaa B, Monassier L, Reutenauer L, Messaddeq N, Cartier N et al. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia. Nat Med 2014; 20: 542\u2013547.","journal-title":"Nat Med"},{"key":"BFgt201661_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/hmg\/8.3.425","volume":"8","author":"A Wong","year":"1999","unstructured":"Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F et al. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 1999; 8: 425\u2013430.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR22","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/11.24.3055","volume":"11","author":"ML Jauslin","year":"2002","unstructured":"Jauslin ML, Wirth T, Meier T, Schoumacher F . A cellular model for Friedreich ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet 2002; 11: 3055\u20133063.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR23","doi-asserted-by":"publisher","first-page":"e34600","DOI":"10.1371\/journal.pone.0034600","volume":"7","author":"TE Richardson","year":"2012","unstructured":"Richardson TE, Yu AE, Wen Y, Yang SH, Simpkins JW . Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS One 2012; 7: e34600.","journal-title":"PLoS One"},{"key":"BFgt201661_CR24","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/hum.2005.16.947","volume":"16","author":"J Fleming","year":"2005","unstructured":"Fleming J, Spinoulas A, Zheng M, Cunningham SC, Ginn SL, McQuilty RC et al. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors. Hum Gene Ther 2005; 16: 947\u2013956.","journal-title":"Hum Gene Ther"},{"key":"BFgt201661_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/mt.2012.46","volume":"20","author":"F Herbst","year":"2012","unstructured":"Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O et al. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 2012; 20: 1014\u20131021.","journal-title":"Mol Ther"},{"key":"BFgt201661_CR26","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/hmg\/ddr187","volume":"20","author":"GM Palomo","year":"2011","unstructured":"Palomo GM, Cerrato T, Gargini R, Diaz-Nido J . Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells. Hum Mol Genet 2011; 20: 2807\u20132822.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(79)91530-7","volume":"2","author":"PD Lewis","year":"1979","unstructured":"Lewis PD, Corr JB, Arlett CF, Harcourt SA . Increased sensitivity to gamma irradiation of skin fibroblasts in Friedreich's ataxia. Lancet 1979; 2: 474\u2013475.","journal-title":"Lancet"},{"key":"BFgt201661_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1469-1809.1983.tb00988.x","volume":"47","author":"HJ Evans","year":"1983","unstructured":"Evans HJ, Vijayalaxmi, Pentland B, Newton MS . Mutagen hypersensitivity in Friedreich's ataxia. Ann Hum Genet 1983; 47: 193\u2013204.","journal-title":"Ann Hum Genet"},{"key":"BFgt201661_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(81)92337-0","volume":"1","author":"S Chamberlain","year":"1981","unstructured":"Chamberlain S, Cramp WA, Lewis PD . Defects in newly synthesised DNA in skin fibroblasts from patients with Friedreich's ataxia. Lancet 1981; 1: 1165.","journal-title":"Lancet"},{"key":"BFgt201661_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/BJ20101116","volume":"432","author":"R Thierbach","year":"2010","unstructured":"Thierbach R, Drewes G, Fusser M, Voigt A, Kuhlow D, Blume U et al. The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals. Biochem J 2010; 432: 165\u2013172.","journal-title":"Biochem J"},{"key":"BFgt201661_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1242\/dmm.009829","volume":"5","author":"A Martelli","year":"2012","unstructured":"Martelli A, Friedman LS, Reutenauer L, Messaddeq N, Perlman SL, Lynch DR et al. Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia. Dis Model Mech 2012; 5: 860\u2013869.","journal-title":"Dis Model Mech"},{"key":"BFgt201661_CR32","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1038\/cddis.2011.5","volume":"2","author":"I Guccini","year":"2011","unstructured":"Guccini I, Serio D, Condo I, Rufini A, Tomassini B, Mangiola A et al. Frataxin participates to the hypoxia-induced response in tumors. Cell Death Dis 2011; 2: e123.","journal-title":"Cell Death Dis"},{"key":"BFgt201661_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.gene.2014.08.043","volume":"551","author":"R Shimizu","year":"2014","unstructured":"Shimizu R, Lan NN, Tai TT, Adachi Y, Kawazoe A, Mu A et al. p53 directly regulates the transcription of the human frataxin gene and its lack of regulation in tumor cells decreases the utilization of mitochondrial iron. Gene 2014; 551: 79\u201385.","journal-title":"Gene"},{"key":"BFgt201661_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/hmg\/11.11.1351","volume":"11","author":"G Karthikeyan","year":"2002","unstructured":"Karthikeyan G, Lewis LK, Resnick MA . The mitochondrial protein frataxin prevents nuclear damage. Hum Mol Genet 2002; 11: 1351\u20131362.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR35","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM . DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858\u20135868.","journal-title":"J Biol Chem"},{"key":"BFgt201661_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ncb1004","volume":"5","author":"A Celeste","year":"2003","unstructured":"Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003; 5: 675\u2013679.","journal-title":"Nat Cell Biol"},{"key":"BFgt201661_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mrrev.2013.02.001","volume":"753","author":"V Valdiglesias","year":"2013","unstructured":"Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S . \u03b3H2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res\/Rev Mutat Res 2013; 753: 24\u201340.","journal-title":"Mutat Res\/Rev Mutat Res"},{"key":"BFgt201661_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia A, Elledge SJ . The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40: 179\u2013204.","journal-title":"Mol Cell"},{"key":"BFgt201661_CR39","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/ars.2012.4537","volume":"19","author":"Y Shan","year":"2013","unstructured":"Shan Y, Schoenfeld RA, Hayashi G, Napoli E, Akiyama T, Iodi Carstens M et al. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model. Antioxid Redox Signal 2013; 19: 1481\u20131493.","journal-title":"Antioxid Redox Signal"},{"key":"BFgt201661_CR40","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/jvi.71.9.6641-6649.1997","volume":"71","author":"U Blomer","year":"1997","unstructured":"Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH . Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71: 6641\u20136649.","journal-title":"J Virol"},{"key":"BFgt201661_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/mt.2012.224","volume":"21","author":"A Nowrouzi","year":"2013","unstructured":"Nowrouzi A, Cheung WT, Li T, Zhang X, Arens A, Paruzynski A et al. The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis. Mol Ther 2013; 21: 324\u2013337.","journal-title":"Mol Ther"},{"key":"BFgt201661_CR42","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","volume":"6","author":"V Campuzano","year":"1997","unstructured":"Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997; 6: 1771\u20131780.","journal-title":"Hum Mol Genet"},{"key":"BFgt201661_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/10430340252898984","volume":"13","author":"C Demaison","year":"2002","unstructured":"Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803\u2013813.","journal-title":"Hum Gene Ther"},{"key":"BFgt201661_CR44","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nbt0997-871","volume":"15","author":"R Zufferey","year":"1997","unstructured":"Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D . Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871\u2013875.","journal-title":"Nat Biotechnol"},{"key":"BFgt201661_CR45","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463\u20138471.","journal-title":"J Virol"},{"key":"BFgt201661_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1182\/blood-2010-05-282707","volume":"117","author":"NJ Ward","year":"2011","unstructured":"Ward NJ, Buckley SMK, Waddington SN, VandenDriessche T, Chuah MKL, Nathwani AC et al Codon optimization of human factor VIII cDNAs leads to high-level expression, vol. 117 Blood 2011; 117: 798\u2013807.","journal-title":"Blood"},{"key":"BFgt201661_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1242\/dmm.018952","volume":"8","author":"S Anjomani Virmouni","year":"2015","unstructured":"Anjomani Virmouni S, Ezzatizadeh V, Sandi C, Sandi M, Al-Mahdawi S, Chutake Y et al A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia Dis Model Mech 2015; 8: 225\u2013235.","journal-title":"Dis Model Mech"},{"key":"BFgt201661_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.gt.3302440","volume":"12","author":"S Charrier","year":"2004","unstructured":"Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA et al. A lentiviral vector encoding the human Wiskott\u2013Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 2004; 12: 597\u2013606.","journal-title":"Gene Ther"},{"key":"BFgt201661_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ymthe.2005.07.358","volume":"12","author":"M Themis","year":"2005","unstructured":"Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005; 12: 763\u2013771.","journal-title":"Mol Ther"},{"key":"BFgt201661_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/em.10207","volume":"43","author":"SK Greenwood","year":"2004","unstructured":"Greenwood SK, Hill RB, Sun JT, Armstrong MJ, Johnson TE, Gara JP et al. Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Enviro Mol Mutagen 2004; 43: 36\u201344.","journal-title":"Enviro Mol Mutagen"},{"key":"BFgt201661_CR51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.mito.2010.12.003","volume":"11","author":"MA Selak","year":"2011","unstructured":"Selak MA, Lyver E, Micklow E, Deutsch EC, \u00d6nder \u00d6, Selamoglu N et al. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion 2011; 11: 342\u2013350.","journal-title":"Mitochondrion"},{"key":"BFgt201661_CR52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ymgme.2010.07.001","volume":"101","author":"EC Deutsch","year":"2010","unstructured":"Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab 2010; 101: 238\u2013245.","journal-title":"Mol Genet Metab"},{"key":"BFgt201661_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nbd.2011.02.016","volume":"42","author":"C Sandi","year":"2011","unstructured":"Sandi C, Pinto RM, Al-Mahdawi S, Ezzatizadeh V, Barnes G, Jones S et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis 2011; 42: 496\u2013505.","journal-title":"Neurobiol Dis"},{"key":"BFgt201661_CR54","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 MD, Pianese L, Coss\u00e9e M, Cavalcanti F et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996; 271: 1423\u20131427.","journal-title":"Science"},{"key":"BFgt201661_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/cyto.a.21171","volume":"81A","author":"EC Bourton","year":"2012","unstructured":"Bourton EC, Plowman PN, Zahir SA, Senguloglu GU, Serrai H, Bottley G et al. Multispectral imaging flow cytometry reveals distinct frequencies of \u03b3-H2AX foci induction in DNA double strand break repair defective human cell lines. Cytometry Part A 2012; 81A: 130\u2013137.","journal-title":"Cytometry Part A"},{"key":"BFgt201661_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4236\/jct.2013.411A006","volume":"4","author":"EC Bourton","year":"2013","unstructured":"Bourton EC, Plowman PN, Harvey AJ, Zahir SA, Parris CN . The PARP-1 inhibitor olaparib causes retention of \u03b3-H2AX foci in BRCA1 heterozygote cells following exposure to gamma radiation. J Cancer Therapy 2013; 4: 44.","journal-title":"J Cancer Therapy"},{"key":"BFgt201661_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","volume":"16","author":"E Riballo","year":"2004","unstructured":"Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell 2004; 16: 715\u2013724.","journal-title":"Mol Cell"},{"key":"BFgt201661_CR58","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/path.2839","volume":"223","author":"GN Pitiyage","year":"2011","unstructured":"Pitiyage GN, Slijepcevic P, Gabrani A, Chianea YG, Lim KP, Prime SS et al. Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J Pathol 2011; 223: 604\u2013617.","journal-title":"J Pathol"},{"key":"BFgt201661_CR59","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1073\/pnas.0603779103","volume":"103","author":"TM Marti","year":"2006","unstructured":"Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE . H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA 2006; 103: 9891\u20139896.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gt201661.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201661","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gt201661.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:34:21Z","timestamp":1684431261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFgt201661"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.61","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]},"assertion":[{"value":"14 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}